Depixus
PrivateLast Round
Series A
Dec 15, 2021
Est. Valuation
$6.71M
Total Funding Raised
$39.82M
Company Overview
Depixus operates in Healthcare & Life Sciences and is based in Courbevoie. Its latest recorded funding round was a Series A round in December 2021.
Depixus is a biotechnology company that provides innovative technology for real-time analysis of individual biomolecular interactions at scale, allowing researchers to swiftly analyze full genomic regions and uncover new biological pathways and disease mechanisms for precision medicine development.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Depixus Comparables
Compare Depixus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LUMICKS | 81% | |
| Nicoya Lifesciences Inc. | 81% | |
| Fida Biosystems | 80% |
For institutional investors. Book with your work email.
Depixus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 15, 2021 | ||||
| Grant | Nov 1, 2018 | ||||
| Grant | Sep 1, 2016 | ||||
| Seed | May 6, 2016 | ||||
| Grant | Jun 1, 2015 |
For institutional investors. Book with your work email.
Depixus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| European Commission (Horizon Europe) | Grant |
| Arix Bioscience | Seed, Series A |
| Lansdowne Partners | Series A |
| Casdin Capital | Series A |
| Bpifrance | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 15, 2021
$35M round led by Lansdowne Partners and Bpifrance.
- May 6, 2016
$1.41M round led by Arix Bioscience.
For institutional investors. Book with your work email.
Depixus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Depixus's valuation, stock price, and market status.
Is Depixus a public or private company?
Depixus is a private company.
What is the current stock price of Depixus?
Depixus is a private company, so its shares have no public market price. Caplight tracks Depixus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Depixus worth (valuation)?
Depixus's valuation is estimated at $6.7M based on funding round data.
Can I buy Depixus stock?
Depixus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Depixus's last funding round?
Depixus's most recent funding round was Series A on December 15, 2021.
Who are the main investors in Depixus?
Key investors in Depixus include Lansdowne Partners, Bpifrance.
Will Depixus IPO soon?
No public IPO plans have been announced for Depixus.
How can I track Depixus secondary market activity?
Caplight tracks bids, offers, and trades in Depixus's shares on secondary markets.